Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
October-2020 Volume 20 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2020 Volume 20 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Puerarin alleviates cisplatin‑induced acute renal damage and upregulates microRNA‑31‑related signaling

  • Authors:
    • Zhen Wu
    • Chunfeng Li
    • Qiang Li
    • Jing Li
    • Xin Lu
  • View Affiliations / Copyright

    Affiliations: Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China, Department of Blood Transfusion, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China, Department of Blood Transfusion, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250033, P.R. China
    Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3122-3129
    |
    Published online on: July 29, 2020
       https://doi.org/10.3892/etm.2020.9081
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Cisplatin (DDP) is a commonly used chemotherapy drug; however, the side effects associated with its use, particularly acute kidney injury (AKI), limit its clinical application. Puerarin is a natural flavonoid extracted from the Chinese medical herb Radix puerariae, which has been reported to alleviate DDP‑induced nephrotoxicity. However, the mechanisms underlying puerarin regulation on microRNA (miR)‑31‑mediated signaling pathways in AKI remain unknown. Thus, the present study aimed to investigate the function of puerarin in a DDP‑induced AKI rat model via reverse transcription‑quantitative PCR and western blot analyses. The results demonstrated that DDP upregulated the levels of miR‑31 in a concentration‑dependent manner, both in vitro and in vivo. Furthermore, DDP significantly increased blood urea nitrogen and malondialdehyde content, serum creatinine and histopathological changes, while significantly decreasing the expression levels of superoxide dismutase, catalase and glutathione S‑transferase in kidney tissues. TUNEL and western blot analyses indicated that DDP increased the expression levels of apoptotic proteins and affected the Numb/Notch1 signaling pathway, which is downstream of miR‑31. The effects induced by DDP were counteracted following treatment with puerarin. Taken together, the results of the present study suggest that puerarin exhibits a renal protective effect against DDP‑induced AKI by upregulating miR‑31 expression and inhibiting the Numb/Notch1 signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Ma G, Cheng W and Ma M: Effect of Docetaxel Combined with Cisplatin Preoperative Neoadjuvant Chemotherapy for Stage III NSCLC. J Coll Physicians Surg Pak. 29:1230–1231. 2019.PubMed/NCBI View Article : Google Scholar

2 

Sultana S, Verma K and Khan R: Nephroprotective efficacy of chrysin against cisplatin-induced toxicity via attenuation of oxidative stress. J Pharm Pharmacol. 64:872–881. 2012.PubMed/NCBI View Article : Google Scholar

3 

Chen H, Liu S, Li M, Huang P and Li X: circ_0003418 Inhibits Tumorigenesis And Cisplatin Chemoresistance Through Wnt/β-Catenin Pathway In Hepatocellular Carcinoma. OncoTargets Ther. 12:9539–9549. 2019.PubMed/NCBI View Article : Google Scholar

4 

Liu W, Wang W, Wang X, Xu C, Zhang N and Di W: Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis. Cancer Lett. 472:59–69. 2020.PubMed/NCBI View Article : Google Scholar

5 

Li Y, Zu X, Hu X, Wang L and He W: Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer. Med Sci Monit. 25:8928–8939. 2019.PubMed/NCBI View Article : Google Scholar

6 

Luo X, Wei J, Yang FL, Pang XX, Shi F, Wei YX, Liao BY and Wang JL: Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b/TUFT1 axis. Cancer Cell Int. 19(323)2019.PubMed/NCBI View Article : Google Scholar

7 

Li WQ, Wu JY, Xiang DX, Luo SL, Hu XB, Tang TT, Sun TL and Liu XY: Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis. Int J Nanomedicine. 14:8345–8360. 2019.PubMed/NCBI View Article : Google Scholar

8 

Ma JQ, Ding J, Xiao ZH and Liu CM: Puerarin ameliorates carbon tetrachloride-induced oxidative DNA damage and inflammation in mouse kidney through ERK/Nrf2/ARE pathway. Food Chem Toxicol. 71:264–271. 2014.PubMed/NCBI View Article : Google Scholar

9 

She S, Liu W, Li T and Hong Y: Effects of puerarin in STZ-induced diabetic rats by oxidative stress and the TGF-β1/Smad2 pathway. Food Funct. 5:944–950. 2014.PubMed/NCBI View Article : Google Scholar

10 

Zhong Y, Zhang X, Cai X, Wang K, Chen Y and Deng Y: Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats. PLoS One. 9(e85690)2014.PubMed/NCBI View Article : Google Scholar

11 

Wang L, Lin S, Li Z, Yang D and Wang Z: Protective effects of puerarin on experimental chronic lead nephrotoxicity in immature female rats. Hum Exp Toxicol. 32:172–185. 2013.PubMed/NCBI View Article : Google Scholar

12 

Ma X, Yan L, Zhu Q and Shao F: Puerarin attenuates cisplatin-induced rat nephrotoxicity: The involvement of TLR4/NF-κB signaling pathway. PLoS One. 12(e0171612)2017.PubMed/NCBI View Article : Google Scholar

13 

Wang J, Ni J, Beretov J, Thompson J, Graham P and Li Y: Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer. Crit Rev Oncol Hematol. 145(102860)2020.PubMed/NCBI View Article : Google Scholar

14 

He J, He J, Min L, He Y, Guan H, Wang J and Peng X: Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma. Int J Cancer. 146:1052–1063. 2020.PubMed/NCBI View Article : Google Scholar

15 

Li Y, Quan J, Chen F, Pan X, Zhuang C, Xiong T, Zhuang C, Li J, Huang X, Ye J, et al: miR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1). Biomed Pharmacother. 111:517–526. 2019.PubMed/NCBI View Article : Google Scholar

16 

Chou CH, Tu HF, Kao SY, Chiang CF, Liu CJ, Chang KW and Lin S: Targeting of miR-31/96/182 to the Numb gene during head and neck oncogenesis. Head Neck. 40:808–817. 2018.PubMed/NCBI View Article : Google Scholar

17 

Zhu GF, Chu T, Ruan Z, Zhang M, Zhou M, Zhang Q, Zhang R and Wu L: Inflammation-Related MicroRNAs Are Associated with Plaque Stability Calculated by IVUS in Coronary Heart Disease Patients. J Interv Cardiol. 2019(9723129)2019.PubMed/NCBI View Article : Google Scholar

18 

Peng H, Wang L, Su Q, Yi K, Du J and Wang Z: miR-31-5p promotes the cell growth, migration and invasion of colorectal cancer cells by targeting NUMB. Biomed Pharmacother. 109:208–216. 2019.PubMed/NCBI View Article : Google Scholar

19 

Liu Z, Li H, Su J, Xu S, Zhu F, Ai J, Hu Z, Zhou M, Tian J, Su Z, et al: Numb Depletion Promotes Drp1-Mediated Mitochondrial Fission and Exacerbates Mitochondrial Fragmentation and Dysfunction in Acute Kidney Injury. Antioxid Redox Signal. 30:1797–1816. 2019.PubMed/NCBI View Article : Google Scholar

20 

Luo Z, Mu L, Zheng Y, Shen W, Li J, Xu L, Zhong B, Liu Y and Zhou Y: NUMB enhances Notch signaling by repressing ubiquitination of NOTCH1 intracellular domain. J Mol Cell Biol. 12:345–358. 2020.PubMed/NCBI View Article : Google Scholar

21 

Ding X, Zhu F, Li T, Zhou Q, Hou FF and Nie J: Numb protects renal proximal tubular cells from puromycin aminonucleoside-induced apoptosis through inhibiting Notch signaling pathway. Int J Biol Sci. 7:269–278. 2011.PubMed/NCBI View Article : Google Scholar

22 

Zhang Y, Wang H, Yu L and Chen J: The Puerarin improves renal function in STZ-induced diabetic rats by attenuating eNOS expression. Ren Fail. 37:699–703. 2015.PubMed/NCBI View Article : Google Scholar

23 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

24 

Wu J, Xu L, Sun C, Zhang B, Li J, Sun J, Zhang Y and Sun D: Paeonol alleviates epirubicin-induced renal injury in mice by regulating Nrf2 and NF-κB pathways. Eur J Pharmacol. 795:84–93. 2017.PubMed/NCBI View Article : Google Scholar

25 

Song Q, Zhao Y, Li Q, Han X and Duan J: Puerarin protects against iron overload-induced retinal injury through regulation of iron-handling proteins. Biomed Pharmacother. 122(109690)2020.PubMed/NCBI View Article : Google Scholar

26 

Zhou X, Bai C, Sun X, Gong X, Yang Y, Chen C, Shan G and Yao Q: Puerarin attenuates renal fibrosis by reducing oxidative stress induced-epithelial cell apoptosis via MAPK signal pathways in vivo and in vitro. Ren Fail. 39:423–431. 2017.PubMed/NCBI View Article : Google Scholar

27 

Li X, Zhang H, Pan L, Zou H, Miao X, Cheng J and Wu Y: Puerarin alleviates liver fibrosis via inhibition of the ERK1/2 signaling pathway in thioacetamide-induced hepatic fibrosis in rats. Exp Ther Med. 18:133–138. 2019.PubMed/NCBI View Article : Google Scholar

28 

Gao S, Li L, Li L, Ni J, Guo R, Mao J and Fan G: Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice. J Mol Cell Cardiol. 137:59–70. 2019.PubMed/NCBI View Article : Google Scholar

29 

Song X, Li Z, Liu F, Wang Z and Wang L: Restoration of autophagy by puerarin in lead-exposed primary rat proximal tubular cells via regulating AMPK-mTOR signaling. J Biochem Mol Toxicol. 31(e21869)2017.PubMed/NCBI View Article : Google Scholar

30 

Wang J, Zhou T, Sun Z, Ye T, Zhou S, Li J, Liu Y, Kong L, Tang J, Liu D and Xing HR: Zeb1 Regulates the Symmetric Division of Mouse Lewis Lung Carcinoma Stem Cells Through Numb Mediated by miR-31. Int J Biol Sci. 14:1399–1410. 2018.PubMed/NCBI View Article : Google Scholar

31 

Jadhav S, Ajay AK, Trivedi P, Seematti J, Pellegrini K, Craciun F and Vaidya VS: RNA-binding Protein Musashi Homologue 1 Regulates Kidney Fibrosis by Translational Inhibition of p21 and Numb mRNA. J Biol Chem. 291:14085–14094. 2016.PubMed/NCBI View Article : Google Scholar

32 

Zhu F, Liu W, Li T, Wan J, Tian J, Zhou Z, Li H, Liu Y, Hou FF and Nie J: Numb contributes to renal fibrosis by promoting tubular epithelial cell cycle arrest at G2/M. Oncotarget. 7:25604–25619. 2016.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wu Z, Li C, Li Q, Li J and Lu X: Puerarin alleviates cisplatin‑induced acute renal damage and upregulates microRNA‑31‑related signaling. Exp Ther Med 20: 3122-3129, 2020.
APA
Wu, Z., Li, C., Li, Q., Li, J., & Lu, X. (2020). Puerarin alleviates cisplatin‑induced acute renal damage and upregulates microRNA‑31‑related signaling. Experimental and Therapeutic Medicine, 20, 3122-3129. https://doi.org/10.3892/etm.2020.9081
MLA
Wu, Z., Li, C., Li, Q., Li, J., Lu, X."Puerarin alleviates cisplatin‑induced acute renal damage and upregulates microRNA‑31‑related signaling". Experimental and Therapeutic Medicine 20.4 (2020): 3122-3129.
Chicago
Wu, Z., Li, C., Li, Q., Li, J., Lu, X."Puerarin alleviates cisplatin‑induced acute renal damage and upregulates microRNA‑31‑related signaling". Experimental and Therapeutic Medicine 20, no. 4 (2020): 3122-3129. https://doi.org/10.3892/etm.2020.9081
Copy and paste a formatted citation
x
Spandidos Publications style
Wu Z, Li C, Li Q, Li J and Lu X: Puerarin alleviates cisplatin‑induced acute renal damage and upregulates microRNA‑31‑related signaling. Exp Ther Med 20: 3122-3129, 2020.
APA
Wu, Z., Li, C., Li, Q., Li, J., & Lu, X. (2020). Puerarin alleviates cisplatin‑induced acute renal damage and upregulates microRNA‑31‑related signaling. Experimental and Therapeutic Medicine, 20, 3122-3129. https://doi.org/10.3892/etm.2020.9081
MLA
Wu, Z., Li, C., Li, Q., Li, J., Lu, X."Puerarin alleviates cisplatin‑induced acute renal damage and upregulates microRNA‑31‑related signaling". Experimental and Therapeutic Medicine 20.4 (2020): 3122-3129.
Chicago
Wu, Z., Li, C., Li, Q., Li, J., Lu, X."Puerarin alleviates cisplatin‑induced acute renal damage and upregulates microRNA‑31‑related signaling". Experimental and Therapeutic Medicine 20, no. 4 (2020): 3122-3129. https://doi.org/10.3892/etm.2020.9081
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team